BLK
BlackRock, Inc.
BLK's fundamentals are mixed, but it looks expensive: trading at 28x earnings, above its usual 22x.
PSEC
Prospect Capital Corporation
There isn't enough reported data to score PSEC yet.
BLK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BLK's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BLK.
PSEC Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Stable | |
| N/A | |
| N/A |
PSEC's profitability is currently stable, but its revenue is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like PSEC.
BLK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 19x | $848 | -30% |
| Fair | 22x | $973 | -20% |
| Expensive | 26x | $1,149 | -5.5% |
| Current | 28x | $1,217 | — |
Historical ranges are pointers, not guarantees.
BLK's PE is in its expensive range at 28x.
PSEC PE Valuation
PSEC has no meaningful PE right now: it lost money over the past year.
BLK Forward outlook
There aren't enough analyst estimates for BLK to show an outlook.
PSEC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong decline | |
| Decline | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect PSEC's earnings and revenue to decline, with profitability weakening.
BLK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $43.87 | +11% |
| Q2 2026 | $41.73 | -0.4% |
| Q1 2026 | $39.73 | -4.7% |
| Q4 2025 | $35.31 | -17% |
| Q3 2025 | $39.42 | -2.7% |
| Q2 2025 | $41.89 | +4% |
| Q1 2025 | $41.69 | +5.9% |
| Q4 2024 | $42.53 | +16% |
BLK has the stronger earnings trend. Trailing diluted EPS is up 11% for BLK versus PSEC down 505%.
PSEC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.32 | — |
| Q3 2025 | -$0.89 | -$0.67 |
| Q2 2025 | -$1.35 | -497% |
| Q1 2023 | -$0.51 | -124% |
| Q4 2022 | $0.14 | -94% |
| Q3 2022 | $0.62 | -76% |
| Q2 2022 | $1.41 | -44% |
| Q1 2022 | $2.14 | -7.8% |
| Q4 2021 | $2.39 | +103% |
PSEC lost $0.89 per share over the past year, a bigger loss than the year before.
BLK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7.8B | +19% |
| Q2 2026 | $7.1B | +31% |
| Q1 2026 | $6.7B | +27% |
| Q4 2025 | $7B | +23% |
| Q3 2025 | $6.5B | +25% |
| Q2 2025 | $5.4B | +13% |
| Q1 2025 | $5.3B | +12% |
| Q4 2024 | $5.7B | +23% |
BLK has the stronger quarterly revenue trend. Revenue is up 19% for BLK versus down 104% for PSEC.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | 0 points |
| Q2 2026 | 35% | +2.8 points |
| Q1 2026 | 42% | +9.8 points |
| Q4 2025 | 24% | -13 points |
| Q3 2025 | 30% | -8.6 points |
| Q2 2025 | 32% | -5.5 points |
| Q1 2025 | 32% | -3.6 points |
| Q4 2024 | 37% | +2.3 points |
BLK's operating margin was 30% last quarter, about level with the same quarter a year ago, near the bottom of its range since 2019.
PSEC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2022 | $203.3M | -32% |
| Q4 2021 | $293.9M | -17% |
| Q3 2021 | $253.7M | +19% |
| Q2 2021 | $284.3M | +37% |
| Q4 2020 | $353.2M | +753% |
PSEC's revenue has slid since its 2020 peak: −$11M last quarter, down 104% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2022 | 81% | -1.9 points |
| Q4 2021 | 86% | -0.3 points |
| Q3 2021 | 84% | +4.6 points |
| Q2 2021 | 86% | +7.2 points |
| Q1 2021 | 83% | N/A |
| Q4 2020 | 87% | +114 points |
| Q3 2020 | 79% | N/A |
| Q2 2020 | 79% | N/A |
PSEC's operating margin was 81% last quarter, down 1.9 points from the same quarter a year ago.
BLK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.6B | +95% |
| Q2 2026 | $1.1B | -12% |
| Q1 2026 | -$1.1B | +$120M |
| Q4 2025 | $2.1B | -15% |
| Q2 2025 | $1.3B | -6.1% |
| Q1 2025 | -$1.2B | -$734M |
| Q4 2024 | $2.5B | +35% |
| Q2 2024 | $1.4B | +47% |
BLK's free cash flow was $4.8B over the past year, up 22% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BLK.
PSEC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $381.7M | +37% |
| Q2 2026 | -$43.9M | -$36.3M |
| Q1 2026 | $195.7M | +149% |
| Q4 2025 | $85.6M | -69% |
| Q3 2025 | $279M | +61% |
| Q2 2025 | -$7.6M | -106% |
| Q1 2025 | $78.6M | +$100.8M |
| Q4 2024 | $278.5M | +251% |
PSEC's free cash flow was $619M over the past year, down 1.5% from the year before. Free cash flow isn't a meaningful measure for financial services companies like PSEC.
BLK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -148K shares |
| 1 year | -0.4% | -677K shares |
| 3 years | +9.3% | +14M shares |
| 5 years | +6.2% | +9.6M shares |
| Available history | +4.4% | +7M shares |
BLK has the edge over PSEC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2025 | $396M |
| Q1 2025 | $657M |
| Q4 2024 | $386M |
| Q2 2024 | $519M |
| Q1 2024 | $634M |
| Q4 2023 | $384M |
| Q3 2023 | $396M |
| Q2 2023 | $383M |
PSEC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -44% | -405M shares |
| 1 year | +18% | +81M shares |
| 3 years | -4.2% | -22.9M shares |
| 5 years | +37% | +143M shares |
| Available history | +43% | +157M shares |
PSEC has 524M diluted shares, up 18% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
BLK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.0x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2024 | 0.2x | Very low |
| Q1 2024 | 0.3x | Very low |
| Q4 2023 | 0.1x | Very low |
BLK has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like BLK.
PSEC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2022 | 4.7x | High |
| Q1 2022 | 2.9x | Moderate |
| Q4 2021 | 2.4x | Moderate |
| Q3 2021 | 2.0x | Moderate |
| Q2 2021 | 2.3x | Moderate |
| Q1 2021 | 2.3x | Moderate |
| Q4 2020 | 4.6x | High |
| Q3 2020 | 16.0x | High |
PSEC's net debt is about 4.7 years of its operating earnings (EBITDA), up from 2.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like PSEC.
BLK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.5 | Neutral |
| Stochastic | 79.0 | Neutral |
BLK's weekly RSI is 64 (neutral) and its Stochastic is 79 (neutral).
PSEC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 26.3 | Oversold |
| Stochastic | 13.6 | Oversold |
PSEC's weekly RSI is 26 (oversold) and its Stochastic is 14 (oversold).
BLK PE vs Financial Services Sector
| Metric | BLK | Sector median | Relative |
|---|---|---|---|
| PE | 28x | 13x | 113% above |
| PE % | 97 | 63 | 34 pts above |
BLK is trading at 28x earnings, a 113% premium to the Financial Services sector's median of 13x.
PSEC PE vs Financial Services Sector
| Metric | PSEC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
PSEC has no meaningful PE right now: it lost money over the past year.
BLK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,128.0 | 7.9% above |
| 20 week MA | $1,108.9 | 9.7% above |
| 50 week MA | $1,071.6 | 14% above |
| 100 week MA | $1,051.1 | 16% above |
| 200 week MA | $914.1 | 33% above |
BLK has the edge over PSEC on trend strength, trading above more of its moving averages.
PSEC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.68 | 16% below |
| 20 week MA | $2.01 | 30% below |
| 50 week MA | $2.36 | 40% below |
| 100 week MA | $2.91 | 52% below |
| 200 week MA | $4.40 | 68% below |
PSEC is in a downtrend: it's below all five of its weekly moving averages, and 68% below its 200-week average.
BLK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $503.0 | $707.2 | +41% |
| 2021 | $707.2 | $913.9 | +29% |
| 2022 | $913.9 | $703.9 | -23% |
| 2023 | $703.9 | $811.8 | +15% |
| 2024 | $811.8 | $1,044.2 | +29% |
| 2025 | $1,044.2 | $1,088.1 | +4.2% |
| 2026 YTD | $1,088.1 | $1,216.6 | +12% |
BLK has the edge over PSEC on returns for 2026, with the stronger performance.
PSEC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.51 | $5.46 | -16% |
| 2021 | $5.46 | $8.43 | +54% |
| 2022 | $8.43 | $7.16 | -15% |
| 2023 | $7.16 | $5.99 | -16% |
| 2024 | $5.99 | $4.26 | -29% |
| 2025 | $4.26 | $2.51 | -41% |
| 2026 YTD | $2.51 | $1.41 | -44% |
PSEC has finished four years in a row lower, and it's down 44% so far in 2026.